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Abstract 
Background: In breast cancer, treatment 
decisions are challenging as patients, their 
families and providers need to sort through an 
ever expanding array of options for surgery, 
radiation, reconstruction and systemic 
therapy.  
Objective: To describe efficacy and 
effectiveness of interventions designed to 
improve decision quality in breast cancer care. 
Methods: We describe the competencies 
required of providers and patients to engage 
in shared decision making, and then present 
interventions and metrics that have been shown 
to improve the quality of medical treatment 
decisions. A case study illustrates how decision 
support tools have been implemented in a 
cancer center in the United States. 
Results: Patients and providers face multiple 
decisions after a breast cancer diagnosis and 
too often these decisions are made without 
patients having adequate information or 
involvement. Decision aids, prompt sheets and 
consultation recordings have been shown to 
improve the quality of decisions by increasing 
knowledge, reducing decision conflict and 
improving communication. These tools have 
been successfully integrated in a variety of 
cancer centers, but require some resources 
and infrastructure to make it work. 
Conclusions: Patients, their families and 
providers need to work together to select 
cancer treatments. These interactions are 
complex and can be improved through the 
implementation of decision support. 
Resumen
Antecedentes: En cáncer de mama, las 
decisiones de tratamiento son difíciles ya que 
los pacientes, sus familias y los proveedores 
necesitan elegir entre una gama cada vez 
mayor de opciones de cirugía, radioterapia, 
reconstrucción y terapia sistémica.
Objetivo: Describir la eficacia y la 
efectividad de las intervenciones diseñadas 
para mejorar la calidad de la decisión en el 
tratamiento del cáncer de mama.
Métodos: Se describen las competencias 
requeridas de los proveedores y los pacientes 
para comprometerse en la toma de decisiones 
compartida. A continuación presentamos 
las intervenciones e instrumentos que han 
demostrado mejorar la calidad de las decisiones 
de los tratamientos médicos. Un estudio de 
caso ilustra cómo las herramientas de apoyo 
a las decisiones se han llevado a cabo en un 
centro oncológico en los Estados Unidos.
Resultados: Los pacientes y los proveedores 
se enfrentan a múltiples decisiones después 
de un diagnóstico de cáncer de mama y 
con demasiada frecuencia estas decisiones 
se hacen sin que los pacientes tengan una 
adecuada información o participación. Las 
ayudas a la decisión, las hojas y los registros 
de la consulta se han demostrado que mejoran 
la calidad de las decisiones, al aumentar el 
conocimiento, reducir el conflicto decisional 
y mejorar la comunicación. Estas herramientas 
se han integrado con éxito en una variedad de 
centros oncológicos, pero para su adecuado 
funcionamiento requieren de determinados 
recursos e infraestructura.
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Introduction
After a diagnosis of cancer, breast cancer 
patients have a dual burden. They need 
to come to terms with a life threatening 
diagnosis, and they need to make a 
decision about treatment. Most women 
with breast cancer face multiple treatment 
decisions, about surgery, reconstruction, 
and adjuvant therapy. Many patients 
struggle with the decision making period 
and report significant anxiety and distress 
during the time between diagnosis and 
treatment(1,2). 
In the United States, studies have 
documented variation in treatment rates 
that suggests that whether a woman gets a 
lumpectomy or mastectomy may be more 
influenced by where she lives and which 
doctor she sees than by her preferences 
for keeping or losing her breast(3). In 
quality initiatives, variation is often seen 
as a problem that needs to be minimized 
or eliminated. Appropriateness criteria 
and quality measures have been set to 
minimize variation in rates of procedures. 
In breast cancer, rates of breast conserving 
surgery have been promoted as a quality 
criteria, with higher rates indicating 
higher quality care(4). However, the 
appropriate response to practice variation 
differs depending on the situation. 
When a procedure is known to provide 
significant benefits with little or no risk, 
decisions are straightforward. The goal is 
to minimize variation by delivering the 
treatment to all who are eligible. 
But when effectiveness is uncertain, 
when the increase in benefit is marginal, 
or when the treatment has significant 
risks or side effects, the decisions are 
complex. In these situations, the right 
treatment cannot be determined by 
medical features, rather the right treatment 
is the one that best achieves an informed 
patient’s goals. Consensus statements and 
practice guidelines for many breast cancer 
treatment decisions now recognize the 
appropriateness of multiple options and 
the importance of incorporating patients’ 
preferences when selecting treatment(5, 6).
Consider the following three examples 
where patients and providers must make 
tradeoffs: 
·	 Mastectomy or lumpectomy: patients 
must consider how they feel about 
keeping their breast, and whether 
it outweighs concerns about having 
radiation therapy, the small increased 
chance of ipsilateral recurrence, and 
the possibility of needed multiple 
excisions to get clear margins. 
·	 Breast reconstruction or not: patients 
must consider how they feel about 
living without a breast, their desire 
for normal appearance in and out of 
clothes, the ease of dressing and daily 
activities with and without a prosthesis, 
and the chance of complications 
and recuperation associated with 
reconstructive surgery. 
·	 Systemic therapy or not: patients 
with stage I disease have a good 
Key words: Decision making, Decision 
aids, breast cancer.
 
Conclusiones: Los pacientes, sus familias 
y los proveedores deben trabajar juntos 
para elegir los tratamientos del cáncer. Estas 
interacciones son complejas y se pueden 
mejorar mediante la implementación del 
apoyo a la decisión. 
Palabras clave: Toma de decisión, ayudas a 
la decisión, cáncer de mama.
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prognosis after local therapy, and 
must consider whether the small 
improvement in survival and reduc-
tion in recurrence is worth the side 
effects and chance of serious com-
plications from these therapies. 
How well do patients and providers 
make these kinds of treatment decisions? 
Several studies suggest that patients 
have significant gaps in knowledge. For 
example, in a large population based 
sample of early breast cancer patients, only 
half understood that survival was the same 
with either mastectomy or lumpectomy(7). 
In another study, patients believed that 
adjuvant chemotherapy would provide 
about an 80% reduction in their risk of 
recurrence, at least twice as much as it 
actually provides(8). 
When patients are informed about the 
options and have realistic expectations 
about the benefits and harms, it changes 
their goals and their decisions. Peele et 
al (2005) randomized early stage breast 
cancer patients to view a decision aid 
that presented their absolute risk of 
recurrence and survival with and without 
chemotherapy. In the decision aid group, 
57% chose to have chemotherapy 
compared to 87% of those in usual care(9). 
Providing treatment to a patient who 
would not have chosen it had they been 
informed, is problematic. 
In surgery, there is a growing trend for 
using checklists to ensure that everything 
that should happen in the operating room 
does happen(10,11). Equally important is 
making sure that the right patient is in 
the operating room in the first place, and 
that the right operation is being done for 
that patient. The former is concerned with 
the execution of the decision, the latter is 
concerned with the quality of the decision 
making process. This paper describes 
the evidence base for decision support 
interventions aimed at improving decision 
quality, and presents an example of their 
implementation in a U.S. cancer center. 
Shared decision making: competencies, 
interventions and metrics
In cancer care specifically, and 
medicine more generally, the last few 
decades have seen a shift away from 
paternalistic approach toward a more 
patient-centered approach to decision 
making. The increasing role of patients in 
decisions, however, has created its own set 
of problems. Patients facing cognitive and 
emotional overload may see responsibility 
for decision making as an added burden. 
A more collaborative approach to medical 
decision making, called shared decision 
making, recognizes the critical roles of 
both providers and patients and their need 
for shared responsibility(12-15).
There is a complex set of competencies 
required for doctors and patients to make 
high quality, shared decisions, and to 
implement those decisions effectively. 
Physicians must know the relevant clinical 
evidence, be able to interpret it accurately 
and apply it appropriately to the individual 
patient’s situation. When there are gaps in 
the evidence, providers may need to gather 
outside expert opinion. Then, providers 
must translate the relevant clinical 
evidence in an understandable way to 
patients and family members. Providers 
must also have skills to elicit the patient’s 
goals and concerns and appropriately 
assess which treatment would best achieve 
the patients’ preferences. In some cases, 
the implementation of a treatment choice 
requires significant effort on the part of the 
patient, and providers need to monitor and 
assure sufficient patient motivation and 
self-efficacy to carry out the decision. 
Patients also need many competencies 
to engage in shared decision making. 
Patients often need to adjust to the 
emotional impact of a new and threatening 
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diagnosis, or the debilitating impact of 
painful or bothersome symptoms in order 
to be able to absorb information and 
engage in discussions. Patients often need 
to recognize and be willing to readjust 
their sense of urgency –a common and 
unwarranted need to do something right 
away– when, in fact, there is ample time to 
learn about options and make a considered 
decision. Patients cannot simply show up 
and expect the provider to present the 
information and make a recommendation. 
Rather patients need to prepare for the visit, 
and come ready to discuss their questions 
and concerns. During the visit they need to 
speak up if they do not understand, or if the 
provider is not accurately representing their 
goals and concerns. These competencies 
are especially challenging for patients with 
limited health literacy or numeracy and for 
a growing number of patients in Western 
countries, language barriers impede 
communications. Given the extensive 
set of tasks required to make complex 
decisions, it is not surprising that patients 
and providers do not always do it well. 
Despite these challenges, it is important 
to pay attention to the quality of decisions. 
Poor communication of information about 
illness and treatment is one of the most 
frequent sources of patient dissatisfaction(16). 
Studies have found that poor quality 
decisions can detract not only from patient 
satisfaction, but also from quality of life 
and health outcomes(17-21). Good decisions, 
ones where care is tailored to informed 
patient preferences is have been associated 
with increased patient satisfaction, as 
well as improved quality of life and 
outcomes(22,23). In breast cancer, studies 
suggest that whether the patient reported 
having a choice of surgical treatment had a 
bigger impact on psychological adjustment 
and body image that the treatment itself 
(whether someone had mastectomy 
or lumpectomy)(24-26). Women who are 
involved with their treatment decisions are 
less likely to be anxious or depressed and 
tend to feel more confident and optimistic 
about the future(26-28). 
Patient decision aids 
Many different tools, methods and 
approaches have been developed in an 
attempt to improve the quality of treatment 
choices. Some interventions are focused on 
physicians, such as training or education 
in one or more of the competencies 
described earlier. Other interventions focus 
on patients, such as information booklets 
or brochures, prompt sheets or lists of 
frequently asked questions to use during 
visits, and decision aids. Here, we briefly 
review the patient-focused interventions, 
with specific attention on patient decision 
aids. 
Patient decisions aids (PtDAs) are 
educational materials that are designed to 
support patients in the decision making 
process. PtDAs provide information 
relevant for a specific clinical decision 
about a test or treatment, such as a 
description of the disease, the available 
options and the potential outcomes. 
Often PtDAs will provide probabilities 
of the different outcomes and the timing 
of those outcomes. PtDAs also provide 
values clarification, helping patients 
think through their goals and concerns 
to develop a treatment preference. The 
tools are available in a variety of media, 
print, audio/visual and Internet, and some 
including health coaching component. 
The International Patient Decision Aids 
Standards group has generated consensus 
around a core set of twelve criteria for 
PtDAs. These twelve areas highlight the 
complexity of these tools, and place 
a strong emphasis not only on careful 
interpretation of the medical evidence, but 
also on balance (e.g. that the options are 
presented equally), conflict of interest (e.g. 
assurance that the developers do not have 
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a financial stake in one or more of the 
options presented), and other factors(29). 
The Cochrane Collaborative systematic 
review of decision aids now includes 
close to 60 randomized trials of these 
tools. In general, studies have found that 
PtDAs increase knowledge and realistic 
expectations, help patients who are 
undecided make a choice, and increase 
patients’ desire for participation, without 
increasing anxiety(30). In a subset analysis 
for elective surgery procedures (e.g. 
herniated disc surgery or elective bypass 
surgery), PtDAs appear to reduce desire 
for surgery by about 20%(30). These tools 
have been evaluated extensively in the US, 
Canada, Australia and United Kingdom. 
Although it is likely that they will provide 
similar benefits in Spain, more research 
may be needed to adapt these tools for 
use in different countries and cultures(31). 
Prompt sheets and recordings
Some decision aids have worksheets 
or prompt sheets that help patients think 
through their questions for the doctor. Studies 
have found that simply prompting patients 
to make a list of questions, even without 
the educational component of a decision 
aid, can lead to improved interactions and 
outcomes(32-35). The prompt sheets can be 
based on frequently asked questions, such 
as those identified by the National Cancer 
Institute in a review of cancer patient 
information needs(36). Or, they can be 
organized according to conceptual models 
of decision making(37,38). Some examples 
of prompt sheets are available online at 
http://www.psych.usyd.edu.au/cemped/
com_question_prompt.shtml; http://www.
guidesmith.org/questions-for-your-doctor/; 
and the Ottawa Personal Decision Guide, 
at http://decisionaid.ohri.ca/decguide.html. 
Perhaps equally important for patients 
is to have a record of what happened 
during the visit. Many patient advocates 
recommend that patients bring a family 
member or friend to take notes, because 
they recognize the challenge of trying to 
remember all of the information presented 
by the doctor. Studies that have evaluated 
the impact of providing patients an 
audiorecording of the visit have shown 
that patients value these recordings, and 
that they may protect physicians from 
complaints and legal conflicts(36,39). Even 
better than an audiorecording is a written 
summary in language that patients can 
understand (usually not satisfied by a copy 
of the dictated note). Having a written 
summary that can be reviewed and shared 
with family and friends is ideal, yet this 
practice is not a routine part of cancer care. 
Instruments to measure decision quality 
Seldom are organizational or behavioral 
changes made without reliable metrics and 
measures of quality. Perhaps there would 
be more widespread attention to these 
issues if there were better metrics. For 
example, if cancer centers knew that fewer 
than half of their early stage breast cancer 
patients understood that survival is the 
same with breast conserving therapy and 
mastectomy; or that their patients who felt 
strongly about avoiding radiation therapy 
were just as likely to have lumpectomy as 
mastectomy (indicating a lack of tailoring 
to patients’ preferences) –might that prompt 
concern over the quality of the decision 
making process? 
To promote high decision quality, it 
is important to be able to measure how 
informed patients are and how often 
they get treatments that match their 
goals. For any decision, there is a core 
set of information that patients should 
understand before selecting treatment. For 
example, the following bullets highlight 
some of the key pieces of information that 
a patient should understand before making 
decisions about surgery for breast cancer: 
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·	 In general, patients who have breast 
conserving therapy live as long as 
those who have mastectomy.
·	 For most women, there are two rea-
sonable ways to treat it-breast con-
serving therapy or mastectomy (with 
or without reconstruction). 
·	 Women who have breast conserving 
therapy have a slightly higher chan-
ce of having cancer in the breast 
that they keep compared to women 
who have mastectomy.
·	 Most women who have breast con-
serving therapy are satisfied with 
the way their breast looks after 
treatment.
·	 About 10 to 50 out of 100 women 
who have breast conserving therapy 
will need to have more than one 
operation to remove the tumor com-
pletely.
This doesn’t represent all the information 
patients need to know but does cover some 
of the key issues that are relevant when 
trying to decide between the choices. 
Once they understand this information, 
patients then need to take time to consider 
what the different possible options might 
be like for them, in their lives. Before 
the diagnosis, most women have little 
experience with cancer treatments, and do 
not know what it will be like to live without 
a breast, or to experience premature 
menopause due to chemotherapy. The 
patient who imagines incorrectly the 
quality-of-life impact of a future health 
state is likely to make a poor decision(40-42). 
Also, preferences are only opinions, and 
opinions can be well informed or poorly 
informed, and they change over time(43). 
It is important for clinicians to be able 
to help patients think through their goals. 
Thus, for example, providers might ask: 
“How do you feel about keeping your 
breast?” “How important is it to avoid 
radiation therapy?” “How do you feel about 
removing your breast, will that give you 
peace of mind?” Answers to such questions 
can help discriminate among women who 
may prefer mastectomy over lumpectomy. 
This type of assessment, both the 
knowledge and patients’ priorities can be 
done informally during the conversation, 
or administered as an instrument. Sepucha 
and colleagues have worked to develop 
decision quality instruments (DQIs) for 
breast cancer, and other common medical 
decisions(44-46). The Breast Surgery DQI 
has three parts, a set of decision-specific 
knowledge items that are summed to a 
knowledge score, a set of items that ask 
about the interactions with health care 
providers, and a set of goals and concerns 
that are used to calculate the percentage 
of patients who received treatments that 
matched their goals. Annex 1 shows some 
of the knowledge questions and goals 
included in the survey instrument.
The responses can be used as a screen 
before a visit to diagnose gaps in patient 
understanding, assess patient priorities, and 
assess the patient’s attitudes on the risk-
benefit profiles of treatments. If administered 
after a decision has been made, the DQI 
can be used to audit the quality of the 
decision and evaluate quality of decision 
support tools. Dartmouth Hitchcock Breast 
Center implemented a short screening 
version of the breast surgery DQI and found 
that after integrating video-based decision 
aids that patients were consistently well 
informed, with more than 90% answering 
correctly that survival was the same with 
either surgery(47). Further, they were able 
to document that treatments were being 
appropriately tailored to patients’ goals.
Case Study
The case study describes the 
implementation and evaluation of decision 
support tools for breast cancer patients 
at the Breast Cancer Center (BCC) at the 
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University of California San Francisco 
(UCSF). Dr. Laura Esserman, Director of 
the BCC, has long championed the cause 
of shared decision making. Since the mid-
1990s, Dr. Esserman has collaborated 
with the authors to study, implement, and 
evaluate decision and communication 
aids.
This collaboration was inspired by the 
identification of three problems during 23 
focus groups involving 250 breast cancer 
survivors in 1994(48). The survivors said that 
newly diagnosed patients lacked access to 
good information; “froze up” during visits 
and did not ask important questions; and 
that even if they did ask questions, doctor 
responses went “in one ear and out the 
other.” The authors found and contributed 
to an evidence base suggesting that these 
needs could be addressed, in order, by 
decision aids, question prompting and 
coaching, and audio-recording and note-
taking(49-52). 
From 1998 to 2003, under the authors’ 
supervision, graduate students and staff at 
the UCSF BCC delivered communication 
aids, which included question-listing, note-
taking, and audio-recording services to 
around 100 patients a year, and maintained 
a lending library of video-based decision 
aids that was accessed by a few dozen 
patients a year(37). In 2004, the Foundation 
for Informed Medical Decision Making 
(FIMDM) selected the UCSF BCC as a 
demonstration site and provided funding 
and other resources to support broader and 
deeper integration of decision support into 
routine clinical care. 
The BCC formed an organizational unit 
called Decision Services with the purpose 
of promoting patient participation in 
treatment decisions. The operations are run 
by a part-time director (author JB), and 1.3 
full-time equivalent staff to oversee training, 
service delivery, and data collection, 
analysis, and reporting for evaluation and 
quality assurance purposes. The delivery 
of the decision support, including decision 
and communication aids, is implemented 
with 2 full-time equivalent staff, in the 
form of 10 staff members, working one day 
a week each on decision services.
Staff members send decision aids to 
patients scheduled for a treatment decision 
making consultation with surgeons, plastic 
surgeons, and medical oncologists. 
Decision Services staff members also 
call the patients and offer to write down 
their question lists, take notes at the 
appointment, and make recordings of the 
patient-physician discussion(53,54).
The BCC is a busy academic cancer 
center. During the 2009 calendar year, BCC 
physicians saw 609 new patients during 
1,322 new visits. The population is largely 
insured, with ethnic and racial diversity 
reflecting San Francisco’s demographics. 
The distributions of patient demographics, 
stage, and treatment choices are listed in 
Table 2. 
The Decision Services leadership 
monitors and continuously improves the 
program’s performance. Here we report on 
three key aspects of Decision Services (1) 
the reach, or how many eligible patients 
are contacted and invited to use the 
services; (2) the effectiveness, or how well 
the services improve decision making and 
communication including, knowledge, 
patient and provider satisfaction and 
decision outcomes; and (3) adoption, or 
how many patients and clinicians accept 
and use the services. 
Reach is determine by the number of 
eligible patients contacted, the number of 
eligible visitors served (some patients have 
more than one visit), and the percent of 
total visits served. For Decision Services, 
eligibility is defined in terms of whether a 
patient has a scheduled appointment with 
a clinician to discuss treatment options for 
a confirmed diagnosis of breast cancer. 
The graph in Figure 1 shows the growth 
in reach for the decision aids and the 
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communication aids as well as number of 
overall visits since the program’s first full 
year of operations.  
The delivery of decision aids has grown 
rapidly and is now leveling off at about 75% 
of new patient visits. It is not expected to 
get much higher because the decision aids 
are not appropriate for all of patients (e.g. 
there is not a decision aid for patients with 
inflammatory breast cancer). The graph also 
provides a contrast between the delivery 
of decision aids, which is automated, 
with the delivery of communication aids 
(abbreviated QLARNT for Question-Listing, 
Table 2. Demographics and treatments rates for UCSF
breast cancer patients in 2009.
N (%)
Race/ethnicity
Caucasian 383 (63%)
Asian 124 (20%)
Hispanic 42 (7%)
African American 43 (7%)
Insurance
Managed Care 369 (61%)
Medicare 226 (37%)
Self Pay 3 (1%)
Stage of disease
0 102 (20%)
1 188 (36%)
2 161 (31%)
3 49 (10%)
4 17 (3%)
Surgery
Lumpectomy 270 (52%)
Mastectomy only 63 (12%)
Mastectomy  and Reconstruction 138 (27%)
No Surgery 47 (9%)
Radiation
Yes 183 (35%)
No 335 (65%)
Chemotherapy
No chemotherapy 310 (60%)
Adjuvant chemotherapy 144 (28%)
Neo-adjuvant 64 (12%)
Hormonal therapy Yes 185 (36%)
No 333 (64%)
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Audio-Recording, and Note-Taking), which 
are subject to labor capacity constraints. 
In a flat-budget context, the reach of 
communication aids has increased from 
17% to 26% through higher utilization of 
labor capacity. At current staffing levels, 
the maximum expected reach with these 
services is about 33%.
Effectiveness of the decision aids 
was determined by assessing patients’ 
knowledge and satisfaction. Over a three 
year period, we received completed 
responses from 549/1,533 visitors (35% 
response rate) and found that knowledge 
increased from an average of 45% (out of 
100%) before viewing the decision aids 
to 74% after viewing the decisions aids 
(p<0.001). Patients were extremely satisfied 
with the decision aids and virtually all 
patients (96%) would recommend them to 
others. 
The impact of the question-listing 
service was determined by the number of 
questions asked, patients’ confidence in 
asking questions, and patient satisfaction. 
The question-listing was associated with 
significant increases in the number of 
questions that patients had (8 before 
versus 24 after the session, p<0.001) and 
in patients’ confidence in asking (6.7/10 
before versus 8.1/10 after, p<0.001). Patient 
satisfaction with the service was also high. 
In addition to these quantitative 
measures, we invite patients to comment 
on the services. The following comments 
illustrate some typical patient reactions:
“I have not seen any other materials 
that have been so helpful and personal. 
The moderators in the video… are 
very knowledgeable, professional 
and compassionate. It also helps 
Figure 1. Increase in reach for the decision and communication aids at the 
University of California San Francisco Breast Cancer Center over five years.
QLARNT=question listing, audio recording and note taking; DA= decision aid; N60s=new patient visits eligible 
for aids
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tremendously to listen to women who 
have ‘been there’ and made their own 
decisions. Thank you for also including 
pictures of some of the final results after 
reconstructive surgery! …Thank you for 
this service.”
– Patient who had viewed breast 
surgery, breast reconstruction and 
systemic therapy decision aid 
programs
“The question listing helped me focus on 
the things I had been thinking about but 
hadn’t written down. Having someone 
taking notes helped me enormously 
because I wasn’t anxious about the 
amount of information I was trying to 
take in – I knew that I would be able to 
review it.... It is an outstanding service.”
– Patient after receiving Communi-
cation aids
As shown in Figure 1, the adoption 
of decision aids in 2009-2010, was high 
reaching 1,023/1,355 eligible clinic 
visitors (75%). We contacted 1,124/1,355 
(83%) of the visitors to offer assistance 
with question-listing, audio-recording, 
and note-taking. Of the 909 respondents, 
607 accepted the communication aids 
(67%), while 28% declined and 5% were 
deemed ineligible after further review. 
Those who declined generally indicated 
that they did not need assistance with 
communication strategies because friends 
or family members were accompanying 
them to help with question-asking, audio-
recording, and note-taking. 
As a further indication of adoption, 
we surveyed patients 4-6 weeks after 
their visits to examine how many actually 
reviewed the aids. We received responses 
from 209/368 patients (57%) who received 
a decision aid and found that the majority 
viewed the videos (78%) and booklets 
(93%). We received responses from 
158/319 patients (50%) who received 
communication aids and found that a 
majority reviewed the question list (68%), 
the consultation summary (83%), and 
the audiotaped recording of the consult 
(56%). For all the services, about half of 
the patients reported sharing them with 
others, and the overwhelming majority 
would recommend them to others.
Decision and communication aids can 
be integrated into routine clinical care 
with documented benefits for patients on 
educational outcomes. The evaluation 
results find similar benefits to those 
reported in randomized trials of decision 
and communication aids, providing 
evidence of effectiveness. Patients and 
physicians alike have embraced shared 
decision making in our clinic. 
One emerging area of concern is the 
maintenance and updating of the decision 
aid content. As with most cancer centers, 
the Breast Care Center is adopting new 
evidence-based practices and some of 
these are not discussed in decision aids. 
For example, the decision aids do not cover 
newer techniques such as nipple-sparing 
mastectomies with breast reconstruction. 
The BCC physicians are exploring ways 
to supplement the packaged decision aids 
with additional materials. 
Conclusion 
Breast cancer patients are increasingly 
seeking more information and more 
participation in decisions about their care. 
The shift in decision making, from a more 
paternalistic approach where the doctor 
decides what to do, to a more shared 
approach represents a fundamental change 
in the way clinical decisions are made. 
Providers and cancer centers need new 
tools, methods and metrics to respond to 
this new demand and ensure high quality 
of treatment decisions.
Many oncologists have already 
adopted tools to help their patients make 
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more informed decisions. The types of 
interventions described here, decision 
aids, question listing or prompt sheets 
and consultation summaries are fairly 
powerful tools that oncologists can use to 
improve the quality of decision making. 
The tools are inexpensive (most are free), 
but oncologists wishing to implement them 
will have to invest some time in setting them 
up, integrating them into their practice and 
adapting them as practices change. 
When newly diagnosed patients turn to 
cancer survivors for advice they often hear: 
“Learn about your condition; make a list 
of questions for your doctor; think about 
what’s important to you; take notes or 
bring someone to take notes for you; make 
a tape recording of your consultation.” 
Studies of these practices have shown that 
they improve the quality of decisions, in 
addition to improving health and quality 
of life outcomes(55,56). Cancer centers and 
cancer providers committed to improving 
the quality of care should consider 
implementing decision support tools to 
help ensure that their patients are informed 
and that the treatments chosen reflect 
patients’ preferences. 
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Annex 1. 
Selected items from the Breast Cancer Surgery Decision Quality Instrument. 
© Massachusetts General Hospital 2010. All rights reserved. Reprinted with permission.
This set of questions asks about some facts that doctors think are important for 
patients to know about breast cancer. The correct answer to each question is based on 
medical research. 
1. For most women with early breast cancer, how much would waiting 4 weeks to 
make a decision about surgery affect their chances of survival?
  A lot 
  Some
  A little or not at all
2. With treatment, about how many women diagnosed with early stage breast cancer 
will eventually die of breast cancer?
  Most will die of breast cancer
  About half will die of breast cancer
  Most will die of something else
3. After which treatment is it more likely that women will need to have another 
operation to remove the tumor?
  Lumpectomy
  Mastectomy 
  Equally likely for both 
4. On average, which women with early breast cancer live longer?
  Women who have a mastectomy
  Women who have lumpectomy and radiation
  There is no difference
5. On average, which women have a higher chance of having cancer come back in 
the breast that has been treated?
  Women who have a mastectomy
  Women who have a lumpectomy and radiation
  There is no difference
What Matters Most to You: This set of questions includes some reasons other women 
give for choosing their breast cancer surgery. We are interested in what is important 
to you. Please mark on a scale from 0 to 10, how important each of the following is to 
you for your decision about surgery.
How important is it to you to . . .  
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Not at all 
important 
Very
Important
Keep your breast? 0 1 2 3 4 5 6 7 8 9 10
Rremove your entire breast to gain 
peace of mind? 0 1 2 3 4 5 6 7 8 9 10
Avoid having radiation? 0 1 2 3 4 5 6 7 8 9 10
Relieve worries about getting breast 
cancer in the future? 0 1 2 3 4 5 6 7 8 9 10
